Publikationen von Tatjana Dose
Alle Typen
Zeitschriftenartikel (18)
1.
Zeitschriftenartikel
Weight-gain independent effect of mirtazapine on fasting plasma lipids in healthy men. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2023)
2.
Zeitschriftenartikel
4 (1), e123786 (2019)
Effect of mirtazapine on metabolism and energy substrate partitioning in healthy men. JCI Insight 3.
Zeitschriftenartikel
4 (1), e123786 (2019)
Effect of mirtazapine on metabolism and energy substrate partitioning in healthy men. JCI INSIGHT 4.
Zeitschriftenartikel
23 (7), S. 653 - 662 (2013)
Resistance to antidepressant treatment is associated with polymorphisms in the leptin gene, decreased leptin mRNA expression, and decreased leptin serum levels. EUROPEAN NEUROPSYCHOPHARMACOLOGY 5.
Zeitschriftenartikel
36 (5), S. 661 - 669 (2013)
Mirtazapine Provokes Periodic Leg Movements during Sleep in Young Healthy Men. SLEEP 6.
Zeitschriftenartikel
21 (Suppl. s1), S. 76 - 76 (2012)
Mirtazapine provokes periodic leg movements during sleep in young healthy men. Journal of Sleep Research 7.
Zeitschriftenartikel
12 (3), S. 177 - 185 (2009)
Macroscopic brain architecture changes and white matter pathology in acromegaly: a clinicoradiological study. Pituitary 8.
Zeitschriftenartikel
34 (2), S. 238 - 248 (2009)
Suppressive effect of mirtazapine on the HPA system in acutely depressed women seems to be transient and not related to antidepressant action. Psychoneuroendocrinology 9.
Zeitschriftenartikel
43 (3), S. 215 - 229 (2009)
Clinical characteristics and treatment outcome in a representative sample of depressed inpatients - Findings from the Munich Antidepressant Response Signature (MARS) project. Journal of Psychiatric Research 10.
Zeitschriftenartikel
13 (Suppl. 1), S. 31 - 32 (2009)
Clinical characteristics and treatment outcome in a representative sample of depressed inpatients - findings from the Munich antidepressant response signature project. International Journal of Psychiatry in Clinical Practice 11.
Zeitschriftenartikel
57, S. 203 - 209 (2008)
Polymorphisms in the drug transporter Gene ABCB1 predict antidepressant treatment response in depression. Neuron 12.
Zeitschriftenartikel
40 (5), S. 210 - 211 (2007)
Polymorphisms in the leptin gene are associated with resistance to antidepressant treatment and lower cognitive performance in depression. Pharmacopsychiatry 13.
Zeitschriftenartikel
62 (4), S. 321 - 326 (2007)
Overweight and obesity affect treatment response in major depression. Biological Psychiatry 14.
Zeitschriftenartikel
17 (Suppl. 1), S. S70 - S71 (2007)
High weight affects treatment response in major depression. European Neuropsychopharmacology 15.
Zeitschriftenartikel
138B (1), S. 48 - 48 (2005)
The cortisol and ACTH response in the combined Dex/CRH test of acutely depressed patients varies significantly between 5-HT2A receptor genotypes. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 16.
Zeitschriftenartikel
38 (5), S. 251 - 251 (2005)
Change in HPA system function predicts treatment response in depression. Pharmacopsychiatry 17.
Zeitschriftenartikel
38 (5), S. 271 - 271 (2005)
Stress coping and personality traits in acute depression and after improvement. Pharmacopsychiatry 18.
Zeitschriftenartikel
97, S. 7452 - 7457 (2000)
Multiple sclerosis: Comparison of copolymer-1-reactive T cell lines from treated and untreated subjects reveals cytokine shift from T helper 1 to T helper 2 cells. Proceedings of the National Academy of Sciences USA